Patricia Ohana
Technik-/Wissenschafts-/F&E-Leiter bei The Hebrew University of Jerusalem
Profil
Patricia Ohana is currently working as a Research Scientist in the Biological Chemistry Department at The Hebrew University of Jerusalem.
Previously, she worked as a Vice President in Clinical Development at BioCancell Therapeutics, Inc.
Aktive Positionen von Patricia Ohana
| Unternehmen | Position | Beginn |
|---|---|---|
| The Hebrew University of Jerusalem | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Patricia Ohana
| Unternehmen | Position | Ende |
|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Technik-/Wissenschafts-/F&E-Leiter | 14.10.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
